Abstract Coronavirus disease-19 (COVID-19)-induced severe acute respiratory syndrome is
a global pandemic. As a preventive measure, human movement is restricted in most of the …

Aims: To evaluate the efficacy and safety of hydroxychloroquine/chloroquine, with or without
azithromycin, in treating hospitalized COVID-19 patients. Materials & methods: Data from …

Background: Antithrombotic treatment, including low molecular weight heparin (LMWH) or
unfractionated heparin (UFH), has been proposed as a potential therapy for coronavirus …

Background The use of hydroxychloroquine or chloroquine (HCQ/CQ) as monotherapy or
combined with azithromycin for the treatment of coronavirus disease 2019 (COVID-19) may …

Abstract Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is known to suppress the
antioxidant system and is likely to aggravate severity of COVID-19, which results in a pro …

Diabetic ketoacidosis (DKA) is a life‐threatening complication of diabetes and is considered
a medical emergency. Euglycemic DKA (EKDA) is a variant of DKA with a normal or …

METHODS: This open-label, randomized controlled trial was conducted from June 13, 2020
to September 21, 2020 in an Ayurvedic hospital that was functioning as a COVID-19 care …

Background: People with diabetes mellitus (DM) have a higher tuberculosis (TB) risk.
Tuberculosis (TB) and diabetes mellitus (DM) are two diverse conditions of immense public …

The aim of the work is to analyze the available scientific information and generalize the main
results of modern research on the causes and risk factors of hypoglycemia in patients with …

Background: Chloroquine is a potent inhibitor of the SARS Coronavirus (SARS-CoV) and
SARS-CoV-2 in in vitro studies, and has been suggested to exhibit antiviral activity against …